FY2024 EPS Estimates for Ascend Wellness Cut by Cormark

Ascend Wellness Holdings, Inc. (OTC:AAWH - Free Report) - Equities researchers at Cormark lowered their FY2024 EPS estimates for Ascend Wellness in a report issued on Wednesday, November 13th. Cormark analyst J. Pytlak now anticipates that the company will post earnings per share of ($0.41) for the year, down from their prior estimate of ($0.35). The consensus estimate for Ascend Wellness' current full-year earnings is ($0.32) per share. Cormark also issued estimates for Ascend Wellness' FY2025 earnings at ($0.23) EPS.

Ascend Wellness (OTC:AAWH - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.03). Ascend Wellness had a negative return on equity of 72.18% and a negative net margin of 15.47%. The business had revenue of $141.65 million for the quarter, compared to analysts' expectations of $144.13 million.

Ascend Wellness Stock Down 6.8 %

OTC:AAWH traded down $0.03 during trading hours on Friday, hitting $0.47. The stock had a trading volume of 691,410 shares, compared to its average volume of 221,432. The company has a market cap of $99.66 million, a PE ratio of -1.13 and a beta of 1.69. The business has a 50 day simple moving average of $0.82 and a two-hundred day simple moving average of $0.95. Ascend Wellness has a 1-year low of $0.42 and a 1-year high of $1.82. The company has a current ratio of 1.47, a quick ratio of 1.29 and a debt-to-equity ratio of 2.61.

Ascend Wellness Company Profile

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.